HomeCompareBKH vs ISRG

BKH vs ISRG: Dividend Comparison 2026

BKH yields 4.00% · ISRG yields 0.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKH wins by $7.8K in total portfolio value
10 years
BKH
BKH
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full BKH calculator →
ISRG
ISRG
● Live price
0.44%
Share price
$452.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$45.46
Full ISRG calculator →

Portfolio growth — BKH vs ISRG

📍 BKH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKHISRG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKH + ISRG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKH pays
ISRG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKH
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
ISRG
Annual income on $10K today (after 15% tax)
$37.55/yr
After 10yr DRIP, annual income (after tax)
$38.64/yr
At 15% tax rate, BKH beats the other by $725.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKH + ISRG for your $10,000?

BKH: 50%ISRG: 50%
100% ISRG50/50100% BKH
Portfolio after 10yr
$24.2K
Annual income
$472.33/yr
Blended yield
1.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ISRG right now

BKH
Analyst Ratings
7
Buy
8
Hold
Consensus: Hold
Price Target
$82.50
+65.0% upside vs current
Range: $81.00 — $84.00
Altman Z
1.0
Piotroski
6/9
ISRG
Analyst Ratings
37
Buy
12
Hold
5
Sell
Consensus: Buy
Price Target
$638.75
+41.1% upside vs current
Range: $550.00 — $750.00
Altman Z
37.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKH buys
0
ISRG buys
0
No recent congressional trades found for BKH or ISRG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKHISRG
Forward yield4.00%0.44%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth5%0%
5-year div CAGR5%0%
Portfolio after 10y$28.0K$20.3K
Annual income after 10y$899.19$45.46
Total dividends collected$6.4K$449.00
Payment frequencyquarterlyquarterly
SectorUtilitiesStock
Analyst consensusHoldBuy
Analyst price target$82.50$638.75

Year-by-year: BKH vs ISRG ($10,000, DRIP)

YearBKH PortfolioBKH Income/yrISRG PortfolioISRG Income/yrGap
1← crossover$11,120$420.00$10,744$44.17+$376.00BKH
2$12,357$458.31$11,541$44.35+$816.00BKH
3$13,721$499.76$12,393$44.53+$1.3KBKH
4$15,227$544.58$13,305$44.69+$1.9KBKH
5$16,885$593.02$14,281$44.84+$2.6KBKH
6$18,713$645.34$15,326$44.98+$3.4KBKH
7$20,724$701.81$16,444$45.11+$4.3KBKH
8$22,938$762.73$17,640$45.23+$5.3KBKH
9$25,372$828.41$18,920$45.35+$6.5KBKH
10$28,047$899.19$20,290$45.46+$7.8KBKH

BKH vs ISRG: Complete Analysis 2026

BKHUtilities

BKH is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in BKH shares.

Full BKH Calculator →

ISRGStock

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Full ISRG Calculator →
📬

Get this BKH vs ISRG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKH vs SCHDBKH vs JEPIBKH vs OBKH vs KOBKH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.